Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
2013
501 citations
Journal Article
Field-Weighted Citation Impact:
34.08
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial | Researchclopedia
·
Sana Klinikum Offenbach
David Cameron
·
University of Edinburgh
Harald Weber
·
Roche (Switzerland)
Dominik Heinzmann
·
Roche (Switzerland)
Lissandra Dal Lago
·
Institut Jules Bordet
Eleanor McFadden
·
Frontier Agriculture (United Kingdom)
Mitch Dowsett
·
National Health Service
Michael Untch
·
Helios Hospital Berlin-Buch
Luca Gianni
·
IRCCS Ospedale San Raffaele
Richard H. Bell
·
Geelong Hospital
Claus-Henning Köhne
·
Klinikum Oldenburg
A. Vindevoghel
Michael Andersson
·
Rigshospitalet
Adrian Murray Brunt
·
Royal Stoke University Hospital
Douglas Otero-Reyes
Santai Song
·
307th Hospital of Chinese People’s Liberation Army
Ian Smith
·
Royal Marsden Hospital
Brian Leyland‐Jones
·
Sanford Research
José Baselga
·
Memorial Sloan Kettering Cancer Center